A clinical trial with lipid nanoparticle BMS-986263 delivering HSP47 siRNA (NCT03420768) in HCV-SVR patients showed reduced collagen, hepatic fibrosis, METAVIR, and Ishak scores, and good tolerability [263]. The gene discussed is SERPINH1; the disease is Hepatic fibrosis.